Insulet Corporation, headquartered in Acton, Massachusetts, outperformed both the S&P 500 Index and the Health Care Select Sector SPDR Fund on July 24, 2025.
2 reports, 1 independent
Updated Jul 24
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Insulet Corporation, headquartered in Acton, Massachusetts, outperformed both the S&P 500 Index and the Health Care Select Sector SPDR Fund on July 24, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Insulet (United States)
insulin delivery device company
Nothing else this week.
Coverage
Newest first; wire copies grouped- BarchartWhat to Expect From Insulet's Q2 2025 Earnings Report Insulet Corporation (PODD), headquartered in Acton, Massachusetts, operates as an innovative medical device company. Valued at $20.2 billion by m
- Unknown outlet